These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 410362
21. Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae. Van Laethem Y, Lagast H, Klastersky J. Antimicrob Agents Chemother; 1983 Mar; 23(3):435-9. PubMed ID: 6221694 [Abstract] [Full Text] [Related]
22. Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin. Van der Auwera P, Klastersky J. Antimicrob Agents Chemother; 1987 Jul; 31(7):1061-8. PubMed ID: 3116918 [Abstract] [Full Text] [Related]
24. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition. Linzenmeier G, Naumann P, Neussel H, Rosin H. J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584 [Abstract] [Full Text] [Related]
25. Synergistic activity of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against Escherichia coli and Klebsiella pneumoniae. Paisley JW, Washington JA. Antimicrob Agents Chemother; 1978 Nov; 14(5):656-8. PubMed ID: 365085 [Abstract] [Full Text] [Related]
26. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)]. Shah PM, Stille W. Arzneimittelforschung; 1978 Nov; 28(9):1539-41. PubMed ID: 383106 [Abstract] [Full Text] [Related]
27. [Effect of combination of hetacillin, cephapirin and amikacin (author's transl)]. Takahashi M, Ichiman Y, Usui Y, Narikawa S, Yoshida K. Jpn J Antibiot; 1979 Aug; 32(8):830-8. PubMed ID: 114683 [Abstract] [Full Text] [Related]
28. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)]. Drugeon HB, Courtieu AL. Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083 [Abstract] [Full Text] [Related]
29. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria. Isaksson B, Hanberger H, Maller R, Nilsson LE, Nilsson M. Scand J Infect Dis Suppl; 1990 Apr; 74():129-32. PubMed ID: 2129064 [Abstract] [Full Text] [Related]
31. Comparative evaluation of five aminoglycosides for treatment. Rosin H, Naumann P, Reintjens E, Köhler M. Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656 [Abstract] [Full Text] [Related]
32. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. Pechère JC, Marchou B, Michéa-Hamzehpour M, Auckenthaler R. J Antimicrob Chemother; 1986 Mar; 17 Suppl A():11-8. PubMed ID: 3086276 [Abstract] [Full Text] [Related]
33. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens. Fu KP, Neu HC. J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298 [Abstract] [Full Text] [Related]
34. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution]. Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Shigeta S, Takahashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Matsumoto T, Kashitani F, Kaku M, Ooe H, Mochida C. Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437 [Abstract] [Full Text] [Related]
35. In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus. Zinner SH, Klastersky J, Gaya H, Bernard C, Ryff JC. Antimicrob Agents Chemother; 1981 Oct; 20(4):463-9. PubMed ID: 6282192 [Abstract] [Full Text] [Related]
36. In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates. Sutherland CA, Verastegui JE, Nicolau DP. Ann Clin Microbiol Antimicrob; 2016 Jun 17; 15(1):39. PubMed ID: 27316973 [Abstract] [Full Text] [Related]
37. [Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli]. Nicoletti G, Russo G, Toscano MA, Gismondo MR. Boll Ist Sieroter Milan; 1979 Jan 31; 57(6):713-7. PubMed ID: 121911 [Abstract] [Full Text] [Related]
38. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution]. Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Fujime M, Fujita K, Shigeta S, Watanabe J, Igari J, Ogiwara M, Ishibashi K, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Matsumoto T, Kashitani F, Murai M, Ooe H, Nishikawa M, Watanabe K, Kobayashi Y, Uchida H, Oka T, Mochida C. Jpn J Antibiot; 1999 Feb 31; 52(2):93-129. PubMed ID: 10221177 [Abstract] [Full Text] [Related]
39. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin. Knothe H. J Infect Dis; 1976 Nov 31; 134 SUPPL():S271-4. PubMed ID: 825585 [Abstract] [Full Text] [Related]
40. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Garraffo R, Drugeon HB, Dellamonica P, Bernard E, Lapalus P. Antimicrob Agents Chemother; 1990 Apr 31; 34(4):614-21. PubMed ID: 2111658 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]